Dysgerminoma: Clinical Trials

1 trial for Dysgerminoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Dysgerminoma: new trials by email Literature Review of Dysgerminoma trials Research Report on Dysgerminoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
lapatinib, paclitaxel - Bladder Cancer, Brain and Central Nervous System Tumors
Phase 1CompletedUniversity of California, San Francisco282006-02-012014-07-02

Narrower conditions

Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Central Nervous System Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Stomach Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genital Diseases (1)

Interventions

Albumin-Bound Paclitaxel (1)  ·  Lapatinib (1)  ·  Paclitaxel (1)  ·  Taxes (1)

Sponsors

University of California, San Francisco (1)

Countries

United States (1)

Top investigators

Mark M. Moasser, MD (1)

Results publications

PMID 19706807